Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

Pharmacology of Heparin and Related Drugs: An Update
John Hogwood, Barbara Mulloy, R. Lever, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 2, pp. 328-379
Open Access | Times Cited: 47
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 6, Iss. 2, pp. 664-671
Open Access | Times Cited: 64
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2022) Vol. 6, Iss. 17, pp. 4915-4923
Open Access | Times Cited: 56
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Haijiao Jing, Xiaoming Wu, Mengqi Xiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia
Vincent Labbé, Damien Contou, Nicholas Heming, et al.
JAMA Internal Medicine (2023) Vol. 183, Iss. 6, pp. 520-520
Open Access | Times Cited: 21
COVID-19 Coagulopathy: From Pathogenesis to Treatment
Teba Alnima, Mark M. G. Mulder, Bas C.T. van Bussel, et al.
Acta Haematologica (2022) Vol. 145, Iss. 3, pp. 282-296
Open Access | Times Cited: 30
Incidence of Thrombotic Complications in COVID-19 Patients and the Impact of Antithrombotic Therapy on ICU Mortality
Mohamed Foda Hendi, Zeyad Faoor Alrais, Muhammad Shoaib, et al.
Cureus (2025)
Open Access
Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood
Riten Kumar, Michael J. Rivkin, Leslie Raffini
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 9, pp. 2313-2326
Open Access | Times Cited: 13
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 54, Iss. 3, pp. 420-430
Open Access | Times Cited: 20
Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
Nuria Muñoz‐Rivas, Jesús Aibar, Cristina Gabara-Xancó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5632-5632
Open Access | Times Cited: 18
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial
Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menezes Neves, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102004-102004
Open Access | Times Cited: 11
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Lung (2023) Vol. 201, Iss. 2, pp. 135-147
Open Access | Times Cited: 10
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Sirui Zhang, Yupei Li, Guina Liu, et al.
Thrombosis Journal (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 23
Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review
Εleni Stefanou, Nikolaos Karvelas, Samuel Bennett, et al.
Current Treatment Options in Neurology (2023) Vol. 25, Iss. 4, pp. 71-92
Open Access | Times Cited: 9
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Marco Mangiafico, Andrea Caff, Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 15
Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
Lukas J. Weiß, Maria Drayß, Georgi Manukjan, et al.
Blood Advances (2022) Vol. 7, Iss. 11, pp. 2324-2338
Open Access | Times Cited: 14
Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis
Forough Mehrabi, Melina Farshbafnadi, Nima Rezaei
Clinical and Applied Thrombosis/Hemostasis (2023) Vol. 29
Open Access | Times Cited: 8
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
Rosaria Sofia, Mattias Carbone, Giovanni Landoni, et al.
European Journal of Internal Medicine (2022) Vol. 100, pp. 21-24
Open Access | Times Cited: 11
From conventional to living guidelines – faster updates for better informed guidance? A scoping review
Charline Pielenz, Marco Schneider, Eva Salveridou-Hof, et al.
Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen (2022) Vol. 174, pp. 20-31
Open Access | Times Cited: 10
Severe stroke in patients admitted to intensive care unit after COVID-19 infection: Pictorial essay of a case series
Cristian Deana, Daniele Bagatto
Brain Hemorrhages (2021) Vol. 3, Iss. 1, pp. 29-35
Open Access | Times Cited: 13
Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children
Aleksandra S. Dain, Leslie Raffini, Hilary Whitworth
Current Opinion in Pediatrics (2022) Vol. 34, Iss. 3, pp. 261-267
Open Access | Times Cited: 9
The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic
Jun Gu, Yue Wang, Junfeng Zhang, et al.
IJC Heart & Vasculature (2024) Vol. 50, pp. 101353-101353
Open Access | Times Cited: 1
Anticoagulation Among Patients Hospitalized for COVID-19
Claire L. Vale, Peter J. Godolphin, David J. Fisher, et al.
Annals of Internal Medicine (2024)
Closed Access | Times Cited: 1
Occurrence of Thromboembolic Events and Mortality Among Hospitalized Coronavirus 2019 Patients: Large Observational Cohort Study of Electronic Health Records
Alex C. Spyropoulos, James M. Crawford, Yen‐Wen Chen, et al.
TH Open (2022) Vol. 06, Iss. 04, pp. e408-e420
Open Access | Times Cited: 8
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
Eliza Russu, Emil Marian Arbănași, Alexandru Șchiopu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3548-3548
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top